Results 21 to 30 of about 16,609 (196)

What do Cochrane systematic reviews say about interventions for retinal vein occlusion [PDF]

Revista Brasileira de Oftalmologia, 2020
Purpose: To summarize the evidence from Cochrane systematic reviews on interventions for Central or Branch Vein Occlusion. Methods: We included and summarized the results from Cochrane systematic reviews on interventions for both types of occlusion. The
Vânia Mozetic, Natasha Ferreira Santos da Cruz, Matheus Ferreira Santos da Cruz, Murilo Ubukata Polizelli, Nilva Simeren Bueno de Moraes   +4 more
doaj   +2 more sources

BILATERAL SIMULTANEOUS CENTRAL RETINAL VEIN OCCLUSION IN A PATIENT WITH SYSTEMIC HYPERTENSION

Journal of University Medical & Dental College, 2020
The central retinal vein occlusion is caused by age related changes in the retinal vessels. Bilateral central retinal vein occlusion is a relatively rare event. Only less than 10% cases are bilateral.
Basim Mubarik, Aamir Ali Choudhry
doaj  

Oral contraceptive pills: A risk factor for retinal vascular occlusion in in-vitro fertilization patients

Journal of Human Reproductive Sciences, 2013
Retinal vascular occlusion is the most common cause of retinopathy leading to severe visual loss in all age groups. Central retinal vein occlusion (CRVO) is usually seen in older age group and is often associated with systemic vascular diseases. Although
Rohina S Aggarwal, Vineet V Mishra, Somesh V Aggarwal   +2 more
doaj   +1 more source

Recent advances in understanding and managing retinal vein occlusions [version 1; referees: 3 approved]

F1000Research, 2018
Retinal vein occlusions are the second most common form of retinal vascular disease. Previously, laser treatment for branch retinal vein occlusion and intravitreal triamcinolone acetonide for central retinal vein occlusion were the standard of care ...
Daniel D. Esmaili, David S. Boyer
doaj   +1 more source

Central retinal vein occlusion caused by anomalous prepapillary venous loop

Journal of Clinical Ophthalmology and Research, 2021
We present a case of prepapillary venous loop complicated by central retinal vein occlusion (CRVO). A 56-year-old female reported to us with blurring of vision in the right eye, noticed 8 days ago.
Pradeep Gajanan Tekade, H N Ravishankar, Pradeep Sagar   +2 more
doaj   +1 more source

Engineering Approaches to Modify Immunomodulatory Functions of Mesenchymal Stromal Cells (MSCs): Tissue Regeneration and Clinical Application

Advanced Science, EarlyView.
Mesenchymal stromal cells (MSCs) show promise for treating immune‐related disorders through immunomodulation and tissue regeneration. This review gives a brief overview of current clinical approval of MSC therapies. It also discussed how bioengineering, including genetic modification, biomaterial delivery, extracellular vesicles, and iPSC‐derived MSCs,
Sichen Yang, Kejia Li, Ning Wang, Zhen Li, Zhiyong Zhang, Rocky S. Tuan, Yangzi Jiang   +6 more
wiley   +1 more source

Combined central retinal vein occlusion and branch retinal artery occlusion

Indian Journal of Ophthalmology, 2018
Sugandha Goel, Kumar Saurabh, Rupak Roy
doaj   +3 more sources

Single‐Cell Annotation and Localization via Integrating Spatial Transcriptomics Maps the Mouse Ocular Atlas and RAO Dynamics

Advanced Science, EarlyView.
We developed the ASCAL pipeline, integrating complementary spatial transcriptomics, to construct a high‐fidelity mouse whole‐eye single‐cell atlas. Applying ASCAL to a retinal artery occlusion (RAO) model revealed spatially restricted immune activation localized to the ganglion cell layer and the selective depletion of a translationally active, outer ...
Chen Du, Yinming Li, Ziyue Li, Yuedan Wang, Shaopeng Li, Yijie Wang, Yingying Qu, Bingyang Lv, Ying Li, Ting Chen, Yu Zhou, Xuan Xiao   +11 more
wiley   +1 more source

Long-term management of non-ischemic central retinal vein occlusion with fluocinolone acetonide intravitreal implant 190 μg (ILUVIEN®)

Therapeutic Advances in Ophthalmology, 2019
Introduction: Macular edema after central retinal vein occlusion is a common cause of vision loss. Upregulation of vascular endothelial growth factor and higher levels of inflammatory mediators have been involved in the pathogeny of the macular edema in ...
João Coelho, Bernardete Pessoa, Angelina Meireles   +2 more
doaj   +1 more source

Severe visual impairment due to an optic neuropathy and central retinal vein occlusion in a sarcoidosis patient

Journal of Ophthalmic Inflammation and Infection, 2020
Background The ophthalmic manifestation of neurosarcoidosis is varied. The complication of optic neuropathy and central retinal vein occlusion (CRVO) is rare in sarcoidosis.
Miki Hiraoka
doaj   +1 more source